KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 80 filers reported holding KEROS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,480,264 | -28.8% | 77,800 | -10.3% | 0.02% | -36.7% |
| Q2 2023 | $3,484,690 | +44.3% | 86,727 | +53.4% | 0.03% | +30.4% |
| Q1 2023 | $2,414,471 | +24.8% | 56,545 | +40.3% | 0.02% | +43.8% |
| Q4 2022 | $1,935,206 | +96.7% | 40,300 | +122.7% | 0.02% | +77.8% |
| Q1 2022 | $984,000 | +4.8% | 18,097 | +12.8% | 0.01% | 0.0% |
| Q4 2021 | $939,000 | -10.5% | 16,044 | -5.9% | 0.01% | -30.8% |
| Q1 2021 | $1,049,000 | – | 17,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |